Hair loss drug tested to save skin during breast reconstruction
NCT ID NCT07264790
Summary
This early-stage study is testing whether applying the topical medication minoxidil (commonly used for hair loss) to the skin for two weeks before breast reconstruction surgery can improve blood flow to the surgical area. The goal is to see if this reduces skin healing problems and complications after surgery. The study will involve 25 women at high genetic risk for breast cancer who are having preventive mastectomies with reconstruction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Health
Durham, North Carolina, 27710, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.